| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/CEA.12670 |
| P698 | PubMed publication ID | 26542330 |
| P50 | author | Soon S Kwon | Q56993418 |
| Chin Kook Rhee | Q40351138 | ||
| P2093 | author name string | S Y Lee | |
| J H Kim | |||
| Y K Kim | |||
| S W Kim | |||
| C K Park | |||
| T J Kim | |||
| H K Yoon | |||
| P2860 | cites work | Pathology of asthma | Q57901630 |
| A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma | Q57956064 | ||
| Stem cell factor and its receptor c-Kit as targets for inflammatory diseases | Q28115994 | ||
| Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma | Q33321672 | ||
| Asthma. From bronchoconstriction to airways inflammation and remodeling | Q33915771 | ||
| Airway remodelling in asthma: from benchside to clinical practice | Q34105688 | ||
| Remodeling in asthma and chronic obstructive lung disease | Q34457552 | ||
| Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma | Q34624473 | ||
| Remodeling in asthma | Q34629789 | ||
| Refractory asthma: mechanisms, targets, and therapy | Q34788832 | ||
| Theophylline: new perspectives for an old drug | Q35080486 | ||
| Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects | Q35560440 | ||
| Airway remodeling in asthma: therapeutic implications of mechanisms | Q36011393 | ||
| Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD | Q36169173 | ||
| Eosinophil activation of fibroblasts from chronic allergen-induced disease utilizes stem cell factor for phenotypic changes | Q36357396 | ||
| Airway modeling and remodeling in the pathogenesis of asthma | Q37054846 | ||
| Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling. | Q37071840 | ||
| Effect of aging on airway remodeling and muscarinic receptors in a murine acute asthma model | Q37245517 | ||
| The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease | Q37728398 | ||
| Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. | Q38077614 | ||
| Transforming growth factor β and severe asthma: a perfect storm | Q38252852 | ||
| Asthma: pathogenesis and novel drugs for treatment | Q38270994 | ||
| Airway remodelling: the future | Q40157819 | ||
| Theophylline for COPD. | Q42764447 | ||
| Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma | Q42832073 | ||
| The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma | Q43873557 | ||
| Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma | Q44572920 | ||
| Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses | Q44805067 | ||
| Treatment of cockroach allergen asthma model with imatinib attenuates airway responses | Q45063930 | ||
| The expression of stem cell factor and c-kit receptor in human asthmatic airways | Q47346396 | ||
| TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. | Q51695315 | ||
| Effect of nilotinib on airway remodeling in a murine model of chronic asthma. | Q53054357 | ||
| Effect of imatinib on airway smooth muscle thickening in a murine model of chronic asthma. | Q53439673 | ||
| Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. | Q54185709 | ||
| P433 | issue | 5 | |
| P921 | main subject | murine model | Q122890741 |
| P304 | page(s) | 754-763 | |
| P577 | publication date | 2015-11-05 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Effect of roflumilast on airway remodelling in a murine model of chronic asthma | |
| P478 | volume | 46 |
| Q42287278 | Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice. |
| Q45070970 | Developments in the field of allergy in 2016 through the eyes of Clinical and Experimental Allergy |
| Q50002026 | Dose dependent effects of tadalafil and roflumilast on ovalbumin-induced airway hyperresponsiveness in guinea pigs |
| Q64907137 | Innovative Therapies for Severe Asthma. |
| Q36252920 | New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma |
| Q38756064 | Novel approaches to the management of noneosinophilic asthma |
| Q58806313 | Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap |
| Q42368264 | Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout Mice |
| Q58606499 | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases |
| Q90103145 | Risk Factors for Acute Exacerbations in Elderly Asthma: What Makes Asthma in Older Adults Distinctive? |
| Q90048297 | Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease |
Search more.